Clinical Trials Browser

OTHER_GOV × Lung Neoplasms × Sunitinib × Clear all

NCT00620347 2013-06-19

Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer

Phase 2 Completed

Lung Neoplasms, Small Cell Lung Carcinoma